It is the previous investors, including Chalmers Ventures, and K Svets Ventures AB, that together invest four million in Mevia. As our product is ready to help people take the right dose of medicine at the right time we will be utilizing the capital injection to primarily expand sales and marketing. Our product is CE-marked, has been tested to see how it helps users, and the we are confident that the system works.
Tobias Elmquist, Investment Manager at Chalmers Ventures says that "We [Chalmers Ventures] believe this will be a natural part of future care and utilized in the development of new drugs,". You can read more about the investment round in an article by Chalmers Ventures or in an article by Breakit